AMP-activated protein kinase: the current landscape for drug development

GR Steinberg, D Carling - Nature reviews Drug discovery, 2019 - nature.com
Since the discovery of AMP-activated protein kinase (AMPK) as a central regulator of energy
homeostasis, many exciting insights into its structure, regulation and physiological roles …

[HTML][HTML] Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms

S Chen, D Gan, S Lin, Y Zhong, M Chen, X Zou… - Theranostics, 2022 - ncbi.nlm.nih.gov
Aging is a natural process, which plays a critical role in the pathogenesis of a variety of
diseases, ie, aging-related diseases, such as diabetes, osteoarthritis, Alzheimer disease …

Metformin and systemic metabolism

L He - Trends in Pharmacological Sciences, 2020 - cell.com
Metformin can improve patients' hyperglycemia through significant suppression of hepatic
glucose production. However, up to 300 times higher concentrations of metformin …

Metformin: a review of its potential indications

YW Wang, SJ He, X Feng, J Cheng… - Drug design …, 2017 - Taylor & Francis
Metformin is the most commonly prescribed drug for type 2 diabetes mellitus. In recent years,
in addition to glucose lowering, several studies have presented evidence suggesting some …

Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management

F Luo, A Das, J Chen, P Wu, X Li, Z Fang - Cardiovascular Diabetology, 2019 - Springer
With an increasing global burden of coronary artery disease (CAD), early detection and
timely management of risk factors are crucial to reduce morbidity and mortality in such …

Pathogenesis of lipid disorders in insulin resistance: a brief review

P Bjornstad, RH Eckel - Current diabetes reports, 2018 - Springer
Purpose of review Insulin resistance (IR) is recognized to play an important role in the
pathogenesis of dyslipidemia. This review summarizes the complex interplay between IR …

Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy

MF Van Stee, AA de Graaf, AK Groen - Cardiovascular diabetology, 2018 - Springer
Patients with diabetes type 2 have an increased risk for cardiovascular disease and
commonly use combination therapy consisting of the anti-diabetic drug metformin and a …

Metformin role in Parkinson's disease: a double-sword effect

M Alrouji, HM Al-Kuraishy, AI Al-Gareeb… - Molecular and Cellular …, 2024 - Springer
Parkinson's disease (PD) is a common neurodegenerative disease developed due to the
degeneration of dopaminergic neurons in the substantia nigra. There is no single effective …

Metformin: Therapeutic profile in the treatment of type 2 diabetes

CJ Bailey - Diabetes, Obesity and Metabolism, 2024 - Wiley Online Library
Metformin (dimethyl‐biguanide) can claim its origins in the use of Galega officinalis as a
plant treatment for symptoms ascribed to diabetes. Since the first clinical use of metformin as …

Molecular mechanisms of metformin for diabetes and cancer treatment

M Li, X Li, H Zhang, Y Lu - Frontiers in physiology, 2018 - frontiersin.org
Metformin has been the first-line drug treatment for hyperglycemia and insulin resistance for
over 50 years. However, the molecular basis of its therapeutic role remained incompletely …